NuGen Announces Debt Settlement and Amendments to Care4Pharma Share Purchase Agreement
Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") announces that it has agreed to settle an aggregate of €275,000 of indebtedness owed to Care4Pharma B.V. ("Care4Pharma"), an arm's length creditor (the "Creditor"), with respect to monies owed pursuant to the share purchase agreement between the Company and Care4Pharma dated June 30, 2021 (the "Share Purchase Agreement"), through the issuance of an aggregate of 2,000,000...
2024-04-15 5:15 PM EDT
NuGen Announces Completion of Product Training with Sol Millennium as European Markets Expand
Toronto, Ontario--(Newsfile Corp. - January 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of January 30th, 2024, Sol-Millennium Medical Inc.'s ("Sol-M") global sales & marketing team has now completed their in-depth clinical training of NuGen's needle-free InsuJet™ medical device for sales and marketing throughout Europe. Louise Cresswell,...
2024-01-30 5:15 PM EST
NuGen Receives Two Additional Sales Orders for InsuJet(TM) and Expands Distribution into Argentina, Chile, Costa Rica and Peru
Toronto, Ontario--(Newsfile Corp. - January 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that its distribution partner in Mexico, Science-Link Trading SAPI de CV ("Science-Link") has expanded their distribution network to now include Argentina, Chile, Costa Rica and Peru. Science-Link is now also partnering with a large family-owned laboratory and clinic...
2024-01-19 5:15 PM EST
NuGen Medical Signs 5-year Distribution Agreement for InsuJet(TM) with Verrue Consulting Group in Belgium
Toronto, Ontario--(Newsfile Corp. - December 19, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of December 17, 2023, Verrue Consulting Group BV ("Verrue"), a limited liability company incorporated under the laws of Belgium, became an official distributor for NuGen's needle-free InsuJet™ device aimed at improving the delivery of care and the life for...
2023-12-19 5:15 PM EST
NuGen Medical Signs 5-Year Distribution Agreement for InsuJet(TM) with Advance Medical Life Co.
Toronto, Ontario--(Newsfile Corp. - December 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, as of December 12, 2023, Advance Medical Life Co. Ltd. ("Advance Medical"), a limited liability company domiciled in Bangkok, Thailand, became the exclusive distributor for NuGen's needle-free InsuJet™ device aimed at improving the delivery of care and life...
2023-12-14 5:15 PM EST
InsuJet(TM) Registered as a Medical Device in Mexico
Toronto, Ontario--(Newsfile Corp. - November 13, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce the Mexican government has completed the registration of NuGen's needle-free InsuJet™ injection device for sale throughout the country as a medical device. In May 2023, NuGen received its first bulk purchase order from Science-Link Trading SAPI de CV ("Science-Link"), a health and wellness company in Mexico, for the Mexican market for 500 units of...
2023-11-13 5:15 PM EST
Diabetic Lifestyle Subscription Business Launched on Shopify as NuGen's B2C Business Vertical
Toronto, Ontario--(Newsfile Corp. - November 7, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the official launch on Shopify of its diabetic's lifestyle subscription business at www.insujet.com offering diabetics the ability to purchase our revolutionary needle-free InsuJet™ device and consumables online, direct to consumer with a subscription-based model....
2023-11-07 5:15 PM EST
MedTech Industry Leader Ian Heynen Commences CEO Role at NuGen
Toronto, Ontario--(Newsfile Corp. - November 2, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to report that Mr. Ian Heynen has commenced his role as the Company's new Chief Executive Officer focusing his attention on fully commercializing the Company with sales and manufacturing capabilities that drive growth while effectively managing the P&L. Bio of Mr. Ian Heynen:...
2023-11-02 5:15 PM EDT
NuGen Medical Appoints Industry Leader Ian Heynen as CEO
Toronto, Ontario--(Newsfile Corp. - October 12, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle free devices to administer therapeutics subcutaneously, is pleased to announce it has appointed Mr. Ian Heynen as the Company's new Chief Executive Officer, effective November 1, 2023. Mr. Heynen is recognized in the med-tech industry as a top-performing industry executive with over decades of experience leading technology-driven...
2023-10-12 7:00 AM EDT
Semaglutide - Ozempic(R) is Chemically Stable When Administered Using NuGen's Needle Free InsuJet(TM) Device
Toronto, Ontario--(Newsfile Corp. - October 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle free devices to administer therapeutics subcutaneously, today presented new data from a preliminary trial that semaglutide (Ozempic®) is chemically stable after it is administered through NuGen's InsuJet™ needle-free injection device. "Today's discovery paves the way for future tests to validate the findings and prepare for the rigors of...
2023-10-10 5:15 PM EDT
NuGen Medical Completes Delivery and First Sale of 500 InsuJet(TM) Devices and Consumables in Romania
Toronto, Ontario--(Newsfile Corp. - September 20, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has completed the delivery and sale of the first 500 units of the Company's needle-free InsuJet™ injector device and consumables to SC Trustmed SRL ("Trustmed") in Romania as previously announced on June 12th, 2023. The sale, although small in size, was completed earlier than anticipated and represents a milestone for NuGen as our first completed...
2023-09-20 5:15 PM EDT
NuGen Receives $1.3M Through Early Option and Warrant Exercise
Toronto, Ontario--(Newsfile Corp. - September 11, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has received $1,302,000 through the exercise of 25,290,000 warrants having an exercise price of $0.05 expiring February 14, 2025, and 750,000 options at $0.05 expiring December 13, 2027. "The early exercise of the 5-cent option and warrants has improved the capitalization table considerably while providing additional working capital to the...
2023-09-11 5:15 PM EDT
NuGen Announces Participation at the 2023 Kinvestor Days Virtual Conference Tech Day
Toronto, Ontario--(Newsfile Corp. - September 5, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen"), is pleased to announce that Richard Buzbuzian, NuGen's President, CEO and Director, and Karen Dunlap, Chief Customer Officer and Director, are scheduled to present at the 2023 Kinvestor Days Virtual Conference on September 20, 2023, at 9:00 am PT (12:00 pm ET). More details below. This year's Kinvestor Days is a 2-day virtual conference featuring a stellar lineup of...
2023-09-05 5:15 PM EDT
NuGen Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - August 4, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to provide shareholders the following corporate update. Corporate mission: NuGen's mission is to reduce the daily burden of diabetes care by providing a needle-free insulin injection device and supplies tailored to each diabetic's personal needs with our InsuJet™ device which is approved for sale as a medical device in 42 countries. It is noteworthy that InsuJet™...
2023-08-04 5:15 PM EDT
RETRANSMISSION: NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry
Toronto, Ontario--(Newsfile Corp. - July 26, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has entered into a distribution agreement for its needle-free InsuJet™ medical device and consumables with Sol-Millennium Medical Inc. ("Sol-M") of Chicago, Illinois USA, for a term of five years which NuGen estimates the value at approximately $204 million dollars with estimated gross margins of 72%. Sol-M is now the preferred distributor of...
2023-07-26 8:00 AM EDT
NuGen Signs $204M Distribution Agreement With Global Leader in the Diabetic Industry
Toronto, Ontario--(Newsfile Corp. - July 25, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has entered into a distribution agreement for its needle-free InsuJet™ medical device and consumables with Sol-Millennium Medical Inc. ("Sol-M") of Chicago, Illinois USA, for a term of five years which NuGen estimates the value at approximately $204 million dollars with estimated gross margins of 72%. Sol-M is now the preferred distributor of...
2023-07-25 8:38 PM EDT
NuGen Ships First InsuJet(TM) Devices and Consumables to the UK and Attends Diabetes Professional Care Conference
Toronto, Ontario--(Newsfile Corp. - June 30, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that it has delivered its first shipment of InsuJet™ devices and consumables to Reliance Medical Ltd., the Company's UK distributor and 3PL partner in the UK. NuGen further announces their attendance at the Diabetes Professional Care conference taking place on November 15th and 16th 2023, at Olympia, London. NuGen will be presenting InsuJet™ at...
2023-06-30 5:15 PM EDT
NuGen Medical Devices Receives First Bulk-Order Payment and Will Ship 500 InsuJets(TM) to Mexico
Toronto, Ontario--(Newsfile Corp. - June 23, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce that it has received payment for the first shipment of InsuJet™, our needle-free insulin delivery system, to its Mexican contractor, Science-Link Trading SAPI de CV. 500 InsuJet™ devices will ship to Mexico. This shipment represents the first bulk sale revenues from InsuJet™ for the Company. NuGen further announces that the National Health System (NHS)...
2023-06-23 5:15 PM EDT
NuGen Medical Sells 800 InsuJet(TM) Devices and Consumables in Yemen
Toronto, Ontario--(Newsfile Corp. - June 16, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to report it has sold 800 units of the Company's needle-free InsuJet™ injector device and consumables to Rosheta for Medicines and Medical Supplies in Yemen. The Company anticipates further sales to Rosheta for Medicines and Medical Supplies and will report such sales as they occur. InsuJet™ is registered and authorized for use in Yemen as a medical device. For...
2023-06-16 5:15 PM EDT
Porter Media Engaged by NuGen Medical for Online Marketing of InsuJet(TM)
Toronto, Ontario--(Newsfile Corp. - June 14, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") is pleased to announce it has engaged Porter Media, a growth marketing team that specializes in scaling online businesses, to develop product awareness and grow sales of the Company's needle-free injection device, InsuJet™ which is approved for sale as a medical device in 42 countries around the world. "We are a numbers-first team. Nothing is left to chance, and we know our...
2023-06-14 5:15 PM EDT